LSWE-02 - Lunch break symposium: Clinical Oncology Pharmacy (Supported by Beijing Pharmaceutical Association (BPA)
Meeting room 2.60
Chair(s)
Dr Xiaolin Yue, Beijing Tiantan Hospital, Capital Medical University, China and Dr Luwen Shi International Research Center for Medicinal Administration Peking University, ChinaProgramme
| 12:30 – 12:40 | Opening Dr Xiaolin Yue, Beijing Tiantan Hospital, Capital Medical, University, China |
| 12:40 – 12:55 | Design and evidence standards for antitumor drug clinical trials Dr Yue Yang, School of Pharmaceutical Sciences, Tsinghua University, China Dr Jing Wu, Beijing Friendship Hospital, Capital Medical University, China Dr Lan Zhang, Xuanwu Hospital Capital Medical University, China Dr Ying Zhou, Peking University First Hospital, China Dr Chunyu Li, Cancer Hospital, Chinese Academy of Medical Sciences, China |
| 12:55 – 13:10 | Pharmaceutical care pathways for anti-tumor antibody-based drugs Dr Guohui Li, Cancer Hospital, Chinese Academy of Medical Sciences, China Dr Yang Lin, Beijing Anzhen Hospital, Capital Medical University, China Dr Mengli Chen, Chinese PLA General Hospital, China Dr Ling Tan, Beijing Hospital, China |
| 13:10 – 13:25 | Advances in the treatment and research of anti-tumor drugs Dr Dechun Jiang, Beijing ShiJiTan Hospital, Capital Medical University, China Dr Suying Yan, Xuanwu Hospital Capital Medical University. China Dr Xin Feng, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Berlin Dr Zhuoling An, Beijing Chao-Yang Hospital, Capital Medical University, China Dr Xin Liu, Peking Union Medical College Hospital, China |
| 13:25 – 13:30 |
Summary |